Tuesday, May 16, 2017

Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 5

If you are unable to see the message below, click here to view.
Cancer Gene Therapy


Volume 24, Issue 5 (May 2017)

In this issue
Original Articles

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

September 27-29, 2017 | Seoul, Korea

Presented by: Institute for Basic Science | Institute of Genetics and Developmental Biology, CAS | Nature | Nature Biotechnology




The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials

L Ansari, F Shiehzadeh, Z Taherzadeh, S Nikoofal-Sahlabadi, A A Momtazi-borojeni, A Sahebkar and S Eslami

Cancer Gene Ther 2017 24: 189-193; advance online publication, April 14, 2017; 10.1038/cgt.2017.9

Abstract | Full Text

Original Articles


Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancer

G Sun, L Sun, Y Liu, H Xing and K Wang

Cancer Gene Ther 2017 24: 194-202; advance online publication, March 31, 2017; 10.1038/cgt.2014.82

Abstract | Full Text

Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin-induced cardiotoxicity

A L Pop-Moldovan, N -M Trofenciuc, D A Dărăbanţiu, C Precup, H Branea, R Christodorescu and M Puşchiţă

Cancer Gene Ther 2017 24: 203-207; advance online publication, March 3, 2017; 10.1038/cgt.2017.4

Abstract | Full Text

MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1

Y Liu, Z Niu, X Lin and Y Tian

Cancer Gene Ther 2017 24: 208-214; advance online publication, March 10, 2017; 10.1038/cgt.2017.6

Abstract | Full Text

Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China

H-W Wang, Z-K Xu, Y Song and Y-G Liu

Cancer Gene Ther 2017 24: 215-220; advance online publication, April 14, 2017; 10.1038/cgt.2017.7

Abstract | Full Text

lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1

L Yu, F Fang, S Lu, X Li, Y Yang and Z Wang

Cancer Gene Ther 2017 24: 221-226; advance online publication, April 21, 2017; 10.1038/cgt.2017.10

Abstract | Full Text

In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus

R J S Coelen, M J de Keijzer, R Weijer, V V Loukachov, J K Wiggers, F P J Mul, A C W A van Wijk, Y Fong, M Heger and T M van Gulik

Cancer Gene Ther 2017 24: 227-232; advance online publication, April 14, 2017; 10.1038/cgt.2017.11

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: